Journal of Oncology Practice, Vol 2, No 1 (January), 2006: pp. 1
© 2006
American Society of Clinical Oncology.
DOI: 10.1200/JOP.2.1.1
Douglas W. Blayney, MD
| Because this article has no abstract, we have provided an extract of the first 100 words of the full text.
|
| |
Douglas W. Blayney, MD
|
|
With the new year, changes in two important federal programs are underway. The Centers for Medicare & Medicaid Services (CMS) will implement the 2006 Chemotherapy Demonstration Project. Office-based hematologists and oncologists will receive an additional payment of $23 in conjunction with level 2 through level 5 established patient office visits for patients with one of 13 specified cancer diagnoses. This is the current iteration in what is likely to be a series of pay-for-performance or pay-for-data programs that CMS is implementing. The payments incorporated in this year's demonstration project are likely to be transitional, moving away . . . [Click for More]
Related articles in JOP:
- ASCO's Legislative Conference: NCI, FDA, and CMS Outline Projects to Enhance the Quality of Cancer Care
JOP 2005 1: 149-151.
[Extract]
[Full Text]
|